Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Mazdutide demonstrates weight-loss benefit in US cohort

03 Sep 2026

Once-weekly, subcutaneous mazdutide treatment yields meaningful reduction in bodyweight in a US cohort of adults with obesity or overweight, according to a phase II study.

Mazdutide demonstrates weight-loss benefit in US cohort

03 Sep 2026

Almond-based low carb diet improves nocturnal glycaemic control in T2D

02 Sep 2026

In patients with type 2 diabetes (T2D), following an almond-based low-carbohydrate diet (LCD) helps optimize nighttime time-in-range metrics, according to a study.

Almond-based low carb diet improves nocturnal glycaemic control in T2D

02 Sep 2026

Extremes in BMI linked to poor pregnancy outcomes in ART

02 Sep 2026 bởi

At the high and low extremes, BMI is associated with increased early miscarriage and reduced pregnancy success among patients undergoing assisted reproductive technology (ART), according to data presented at ESHRE 2026.

Extremes in BMI linked to poor pregnancy outcomes in ART

02 Sep 2026

Original New Drug Application Approvals by US FDA (16-31 July 2026)

02 Sep 2026

New drug applications approved by US FDA as of 16-31 July 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 July 2026)

02 Sep 2026

SGLT2i & GLP-1 RA may protect against Parkinson’s disease

02 Sep 2026 bởi

Antidiabetic drugs may exert effects beyond glycaemic control and could influence neurodegenerative risk, with sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) being associated with lower risk of Parkinson’s disease (PD), suggesting potential neuroprotective effects, a Bayesian network meta-analysis has found.

SGLT2i & GLP-1 RA may protect against Parkinson’s disease

02 Sep 2026

Women with PMOS at high risk of ASCVD

31 Aug 2026

The risk of atherosclerotic cardiovascular disease (ASCVD) events increases by more than fourfold in the presence of polyendocrine metabolic ovarian syndrome (PMOS), according to a retrospective study from the US.

Women with PMOS at high risk of ASCVD

31 Aug 2026

Glucose dynamics predict satiety, energy intake in women

27 Aug 2026 bởi

Glucose nadir and rip appear to influence both satiety and subsequent energy intake in healthy young women, independent of post-prandial fluctuations of insulin and other appetite-related gut hormones, according to a study.

Glucose dynamics predict satiety, energy intake in women

27 Aug 2026

DASH diet may protect against heart failure

25 Aug 2026

Individuals with greater adherence to The Dietary Approaches to Stop Hypertension (DASH) diet have reduced risks of heart failure (HF) and HF-related death, as suggested in a study.

DASH diet may protect against heart failure

25 Aug 2026

Chemical used in consumer goods may cause insulin resistance

24 Aug 2026 bởi

Oral administration of bisphenol A (BPA), a synthetic chemical used in consumer products, results in reduced peripheral insulin sensitivity in adults with normal weight, a study has found.

Chemical used in consumer goods may cause insulin resistance

24 Aug 2026

Hepatic response to fructose altered in patients with MASLD

24 Aug 2026

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) show clear patterns of change in phosphate metabolites following oral fructose consumption, suggesting differences in hepatic metabolic response, according to a study.

Hepatic response to fructose altered in patients with MASLD

24 Aug 2026

Tin tức & Cập nhật

Xem bài viết Nội tiết

Xem

Chuyên ngành:

Mazdutide demonstrates weight-loss benefit in US cohort

Mazdutide demonstrates weight-loss benefit in US cohort

Almond-based low carb diet improves nocturnal glycaemic control in T2D

Almond-based low carb diet improves nocturnal glycaemic control in T2D

Extremes in BMI linked to poor pregnancy outcomes in ART

Extremes in BMI linked to poor pregnancy outcomes in ART

Original New Drug Application Approvals by US FDA (16-31 July 2026)

Original New Drug Application Approvals by US FDA (16-31 July 2026)

SGLT2i & GLP-1 RA may protect against Parkinson’s disease

SGLT2i & GLP-1 RA may protect against Parkinson’s disease

Women with PMOS at high risk of ASCVD

Women with PMOS at high risk of ASCVD

Glucose dynamics predict satiety, energy intake in women

Glucose dynamics predict satiety, energy intake in women

DASH diet may protect against heart failure

DASH diet may protect against heart failure

Chemical used in consumer goods may cause insulin resistance

Chemical used in consumer goods may cause insulin resistance

Hepatic response to fructose altered in patients with MASLD

Hepatic response to fructose altered in patients with MASLD